Average Co-Inventor Count = 4.44
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (11 from 2,078 patents)
2. N.v. Innogenetics S.a. (7 from 43 patents)
3. Janssen Biotech, Inc. (6 from 410 patents)
24 patents:
1. 12234280 - Anti-PHF-tau antibodies and uses thereof
2. 11673943 - Methods of binding amyloid beta protein having pyroglutamate at the third amino acid residue (3pE abeta) in vivo using anti-3pE abeta antibodies or antigen-binding fragments thereof
3. 11365244 - Anti-PHF-tau antibodies and uses thereof
4. 11236155 - Antibodies to pyroglutamate amyloid-β and uses thereof
5. 10851156 - Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE Aβ antibodies
6. 10766953 - Anti-PHF-tau antibodies and uses thereof
7. 10633435 - Anti-PHF-tau antibodies and uses thereof
8. 10519223 - Antibodies to pyroglutamate amyloid-β and uses thereof
9. 10196440 - Anti-PHG-tau antibodies and their uses
10. 10000559 - Anti-PHF-tau antibodies and their uses
11. 9939452 - N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
12. 9745371 - Anti-PHF-tau antibodies and their uses
13. 9371376 - Anti-PHF-tau antibodies and their uses
14. 9329189 - N-11 truncated amyloid-beta Aβ11-x monoclonal antibodies and compositions
15. 8911731 - Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof